Cell culture and 3D models at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

115 organizations at SLAS2027 present work in cell culture and 3D models: 92 instrument, consumable and component makers, 16 academic, nonprofit and media organizations, 5 software and service companies and 2 drug developers. Between them they bring 102 presentations to the program. Most represented: GSK, Warsaw University of Technology and Duke University. As of Nov 2, 2026.

All 565 organizations at SLAS2027 →

Format
Top represented
Showing 1–7 of 115 organizations
OrganizationSLAS2027 Attendance
GSK
London, UK
Biopharma
Biopharmaceutical company developing vaccines and medicines in infectious disease, HIV, respiratory, immunology and oncology.
Talk
Mon Feb 1
10–10:25am
Part of People at the Heart of Lab Automation: Building Skills, Careers, and Adoption
Automating DMTA to Accelerate Large Molecule Drug Discovery: The Critical Role of People in Automation Success
Ballroom 6F
Automation and robotics
Session
Mon Feb 1
10am–12pm
People at the Heart of Lab Automation: Building Skills, Careers, and Adoption
Ballroom 6F
Automation and robotics
  1. 10amAutomating DMTA to Accelerate Large Molecule Drug Discovery: The Critical Role of People in Automation SuccessGSK
  2. 10:30amGlobal Automated Science Education GuidelinesCarnegie Mellon University
  3. 11amBioscience Technology expands capabilities and increases capacity in preclinical research.AstraZeneca
Talk
Mon Feb 1
11–11:25am
Part of New Approach Methodologies (NAMs) - Innovations in Preclinical Models for Drug Discovery and Research
Validation of a scalable human liver model to enable mechanistic screening in MASLD
Room 7AB
Cell culture and 3D models
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Chemistry First. Code Last. One Agent, Any Robot: Autonomous Synthesis Driven by Chemical Reasoning
SAILS Pavilion
Automation and robotics
Talk
Mon Feb 1
3–3:25pm
Part of ADMET Automation Success and Innovation
Building an Automated Workcell for Autonomous, Around-the-Clock In Vitro ADME Assays and their Bioanalysis
Ballroom 6F
Automation and robotics
Session
Mon Feb 1
3–5pm
ADMET Automation Success and Innovation
Ballroom 6F
Automation and robotics
  1. 3pmBuilding an Automated Workcell for Autonomous, Around-the-Clock In Vitro ADME Assays and their BioanalysisGSK
  2. 3:30pmHigh-Throughput ADME Screening with Acoustic Ejection Mass SpectrometrySCIEX
  3. 4pmMS Imaging in Preclinical DMPK Studies: Visualizing Drugs, Metabolites and BiomarkersWaters
  4. 4:30pmFrom Vision to Reality: What It Actually Took to Implement a Large-Scale, End-to-End Orchestrated LabJohnson & Johnson
Session
Tue Feb 2
10am–12pm
Sample Management
Room 8
Sample management and tracking
  1. 10amAdvancing Autonomous Mobile Robot: Enabled Off-Hour Operations in AstraZentca Compound Management GroupAstraZeneca
  2. 11amThe Road Matters- Creating a Superhighway for Internal and External Sample ManagementBiogen
  3. 11:30amBuilding for Growth: A Scalable Approach to Sample Management in BiotechTriana Biomedicines
Session
Tue Feb 2
1–1:45pm
Proximity Assays
Room 7AB
Assay development and screening
Talk
Tue Feb 2
3–3:25pm
Part of Automation Technology to Maximize Lead Optimization of Antibodies, Biologics and Synthetic Peptides
From Operators to Directors: Building Agentic DMTA and the Workforce to Run It
Ballroom 6F
Automation and robotics
Session
Tue Feb 2
3–5pm
Automation Technology to Maximize Lead Optimization of Antibodies, Biologics and Synthetic Peptides
Ballroom 6F
Automation and robotics
  1. 3pmFrom Operators to Directors: Building Agentic DMTA and the Workforce to Run ItGSK
  2. 3:30pmTalk, title to be announced
  3. 4pmThe Lean Automation Playbook: Internal Tools for Rapid Assay-to-Production DevelopmentBigHat Biosciences
  4. 4:30pmAutomated High Throughput Ribosome Display Platform Enabled by Variable Cycle qPCRBroad Institute of MIT and Harvard
Talk
Wed Feb 3
11–11:25am
Part of Advancing Next-Generation Drug Delivery Platforms Across Diverse Therapeutic Modalities
Mitigating Challenges to Build a Translationally Relevant Human Plasmacytoid Dendritic Cell Platform for Profiling Type I Interferon Inhibitors
Ballroom 6E
New modalities
Talk
Wed Feb 3
2:30–2:55pm
Part of Enabling the Connection Between Automation Processes/ Platforms for Target Candidate Profile
STELLA: Driving Reproducibility and Efficiency through the Automated Flow Cytometry Workcell
Ballroom 6F
Automation and robotics
Academic
Technical university in Warsaw, including its Faculty of Chemistry and the CEZAMAT advanced materials centre.
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Towards repeatable cardiac organoids in a microfluidic system
SAILS Pavilion
Cell culture and 3D models
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
From gut to brain on a chip: Engineering a human microfluidic platform for compartment-resolved inflammatory crosstalk
SAILS Pavilion
Microfluidics and nanotechnology
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Recreating the small airway microenvironment in a multicompartment Organ-on-a-Chip
SAILS Pavilion
Microfluidics and nanotechnology
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Fe₃O₄@AuNPs@Au@Pt Hybrid Nanoplatforms for Multimodal Anticancer Therapy and Aptamer-Based Cancer Diagnostics
SAILS Pavilion
Microfluidics and nanotechnology
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Valve-Free Lab-on-a-Foil Microfluidic Platform for Automated Electrochemical Immunodetection of Inflammatory Biomarkers
SAILS Pavilion
Assay development and screening
Poster
Mon Feb 1
2–3pm
Part of Poster Session B
Engineering hydrogel docking through microsystem geometry
SAILS Pavilion
Microfluidics and nanotechnology
Talk
Tue Feb 2
4–4:25pm
Part of From Fundamentals to Future Technologies: Micro- and Nano Technologies for Lab Automation
Decoupled solution-phase target recognition and magnetic separation for Point-of-Need electrochemical detection of mycotoxins and genetic biomarkers of toxigenic fungi
Room 7AB
Microfluidics and nanotechnology
Duke University
Durham, NC
Academic
Private research university and academic medical center in Durham, North Carolina.
Talk
Mon Feb 1
10–10:25am
Part of New Approach Methodologies (NAMs) - Innovations in Preclinical Models for Drug Discovery and Research
Building Automated, Data-Driven Digital Twins of Human Tissues for Computational NAMs
Room 7AB
Cell culture and 3D models
Session
Mon Feb 1
10am–12pm
New Approach Methodologies (NAMs) - Innovations in Preclinical Models for Drug Discovery and Research
Room 7AB
Cell culture and 3D models
  1. 10amBuilding Automated, Data-Driven Digital Twins of Human Tissues for Computational NAMsDuke University
  2. 10:30amFrom Patient to Prediction: Harnessing human iPSC-derived New Approach Methodologies for more predictive research and drug discoveryAxol Bioscience
  3. 11amValidation of a scalable human liver model to enable mechanistic screening in MASLDGSK
  4. 11:30amMultilineage immune cell production using off-the-shelf hematopoietic organoids and agnostic bioreactor technologiesHannover Medical School
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Parallelized, multi-modal, high-throughput microscopy provides rapid closed loop guidance for automated liquid handling and cell culture screening
SAILS Pavilion
Automation and robotics
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Mind the Automation Gap: Understanding Laboratory Automation Acceptance in Academic Settings
SAILS Pavilion
Automation and robotics
Talk
Tue Feb 2
11:30–11:55am
Part of Patient-Derived Cell Models for Functional Precision Medicine
Live-Cell Phenotypic and Dynamic Activity Analysis from Label-Free, Longitudinal Quantitative Phase Imaging
Room 7AB
Cell culture and 3D models
Poster
Tue Feb 2
2–3pm
Part of Poster Session D
Enabling Reproducible Organoid-Based New Approach Methodologies Through Parallelized High-Throughput Imaging and Predictive Analytics
SAILS Pavilion
Assay development and screening
Talk
Wed Feb 3
11–11:25am
Part of Advanced Models at Scale: Automating Complex, Physiologically Relevant Cell-Based Assays
High-throughput 3D measurement of fluorescence dynamics in freely moving organisms for next-generation drug discovery experiments
Ballroom 6C
Automation and robotics · Cell culture and 3D models
Genentech
South San Francisco, CA
Biopharma
Biotechnology company and member of the Roche Group, discovering and developing medicines for serious diseases.
Talk
Mon Feb 1
3–3:25pm
Part of Beyond Dose-Response - Perturbation Screens to Uncover Drug Effects in Patient-Derived Cells
Multimodal perturbation screens integrate imaging and transcriptomics in cells and tissues
Room 7AB
Cell culture and 3D models
Session
Mon Feb 1
3–5pm
Beyond Dose-Response - Perturbation Screens to Uncover Drug Effects in Patient-Derived Cells
Room 7AB
Cell culture and 3D models
  1. 3pmMultimodal perturbation screens integrate imaging and transcriptomics in cells and tissuesGenentech
  2. 3:30pmBeyond dose–response: an automation-enabled framework for mapping therapy-persistent cancer cell vulnerabilities across contextsUniversity of California, San Francisco
  3. 4pmCell Painting Reveals Genotype-Specific Responses to Oxidative Stress in a Cellular Model of Age-related Macular DegenerationFundación MEDINA
  4. 4:30pmResolving Functional Heterogeneity in Primary Immune Cell Assays at the Cell-Pair LevelUniversity of California, Los Angeles
Session
Tue Feb 2
10am–12pm
Automation Technology to Maximize Organic Chemistry Synthesis
Ballroom 6F
Automation and robotics
  1. 10amFrom Data to Insights: Building an Integrated HT Chemistry and AI/ML Platform for Modern Drug DiscoveryAbbVie
  2. 10:30amAccelerating DMTA Cycles in Drug Discovery: A Pragmatic ‘Lab-in-the-Loop’ Automation Strategy for High-Throughput SynthesisRoche
  3. 11amAutomating the discovery of new synthesis workflows: a deeper look at how OpenAI and Molecule.one used Maria to make a near autonomous and surprising discovery in organic chemistry.Molecule One
  4. 11:30amMicroSprint: Accelerating Chemical Discovery via Autonomous High-Throughput Experimentation PlatformsA*STAR
Session
Tue Feb 2
2–2:45pm
Sample Management
Ballroom 6C
Sample management and tracking
Talk
Tue Feb 2
3–3:25pm
Part of Omics at Scale
Automating 10x Genomics FLEX: Leveraging a Modular Liquid Handling Architecture for Next-Generation Single-Cell Workflows
Room 8
Genomics, synthetic biology and omics
Academic
Public research university and medical center in Los Angeles.
Talk
Mon Feb 1
4:30–4:55pm
Part of Beyond Dose-Response - Perturbation Screens to Uncover Drug Effects in Patient-Derived Cells
Resolving Functional Heterogeneity in Primary Immune Cell Assays at the Cell-Pair Level
Room 7AB
Cell culture and 3D models
Talk
Tue Feb 2
10:30–10:55am
Part of Patient-Derived Cell Models for Functional Precision Medicine
Talk, title to be announced
Room 7AB
Cell culture and 3D models
Session
Tue Feb 2
2–2:45pm
Academic Drug Discovery
Room 8
Assay development and screening
Talk
Wed Feb 3
1:30–1:55pm
Part of Emerging Next-Generation Cellular Therapies
Combined Silencing of MED12 and Activation of IL2 by Epigenetic Editing Enhances CAR T Anti-tumor Potency
Ballroom 6E
New modalities
Session
Wed Feb 3
1:30–3:30pm
Emerging Next-Generation Cellular Therapies
Ballroom 6E
New modalities
  1. 1:30pmCombined Silencing of MED12 and Activation of IL2 by Epigenetic Editing Enhances CAR T Anti-tumor PotencyUniversity of California, Los Angeles
  2. 2pmTalk, title to be announced
  3. 2:30pmElli - End-to-End Automated High Throughput Electroporation PlatformFraunhofer IPA
  4. 3pmAutomating the Cryogenic Lifecycle of CAR-T Therapies: From Controlled Rate Freezing to Digital CryostorageASKION
Rice University
Houston, TX
Academic
Private research university in Houston, Texas.
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
High Throughput Single-Cell 3D Hydrogel Encapsulation and Co-Encapsulation for Measuring Cancer Cell-Matrix and Cell-Cell Interactions
SAILS Pavilion
Cell culture and 3D models
Poster
Mon Feb 1
1–2pm
Part of Poster Session A
Investigating the Role of O-GlcNAcylation and Its Associated Cellular Heterogeneity Within Ewing Sarcoma Cell Lines
SAILS Pavilion
Genomics, synthetic biology and omics
Talk
Tue Feb 2
11–11:25am
Part of Machine Learning and Generative AI for New Therapeutic Modalities
BEACON-seq: A high-throughput all-by-all framework for screening the activity and specificity of AI-designed de novo DNA-binding proteins
Ballroom 6E
New modalities
Also
Presenting at the meeting, beyond the sessions above
Molecular Devices
San Jose, CA
Instruments
Microplate readers, imaging systems and cell-based screening instruments for life science research and drug discovery.
Booth
Exhibiting at Booth 1526-E
Mon, Feb 19:30am–6:00pmTue, Feb 29:00am–5:00pmWed, Feb 39:00am–1:00pm
Workshop
Sun Jan 31
8:30am–4:30pm
Mastering 3D Cell Culture: A Practical Toolbox from Research to High Throughput
Room 11A
Cell culture and 3D models
Workshop
Tue Feb 2
12–1:15pm
Exhibitor Tutorial: Molecular Devices
Room 4
Talk
Tue Feb 2
3:30–3:55pm
Part of High-Throughput Strategies for Translational Discovery
Accelerating Complex Cell-Based Assays Through AI-Driven Automation with the CellXpress.ai System
Ballroom 6C
Automation and robotics · Assay development and screening
Poster
Wed Feb 3
2:30–3:30pm
Part of Poster Session E
iPSC-Derived Cardiac Organoids as a Human-Relevant Platform for Predictive Cardiotoxicity Screening
SAILS Pavilion
Assay development and screening

Explore the full SLAS2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full SLAS2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in cell culture and 3D models

Tell us what you sell and we’ll find the people at organizations working on cell culture and 3D models most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SLAS2027 by

Exhibit hall

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction